Halozyme Therapeutics
HALO
#1870
Rank
โ‚น965.14 B
Marketcap
โ‚น8,465
Share price
-1.82%
Change (1 day)
35.87%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): โ‚น329.41

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น326.20. In 2025 the company made an earnings per share (EPS) of โ‚น241.87 a decrease over its 2024 EPS that were of โ‚น324.34.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น329.4136.2%
2025โ‚น241.87-25.43%
2024โ‚น324.34
2022โ‚น137.15-48.07%
2021โ‚น264.11196.88%
2020โ‚น88.96-292%
2019-โ‚น46.33-9.09%
2018-โ‚น50.97-237.5%
2017โ‚น37.07-149.38%
2016-โ‚น75.06211.54%
2015-โ‚น24.09-52.73%
2014-โ‚น50.97-24.66%
2013-โ‚น67.6548.98%
2012-โ‚น45.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น65.80-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,863 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น183.54-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น130.66-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚น12.05-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA